Although the incidence and mortality rates for rectal cancer have decreased during the past 20 years
1 morbidity rates after rectal cancer surgery remain high.
2 The cornerstone of rectal cancer treatment has been surgery, often combined with adjuvant therapies, such as radiotherapy and chemotherapy.
3 Patients undergoing resection for rectal cancer can develop a variety of postoperative complications, anastomotic leak (AL) being the most morbid.